This company seems to have been delisted
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
ViewRay
VRAY
0,02138 €
Share price
0.00%
Change (1 day)
-99.32%
Change (1 year)
Categories
ViewRay (VRAY) - Total debt
Total debt on the balance sheet as of March 2023 : €72.81 Million
According to ViewRay's latest financial reports the company's total debt is €72.81 Million. A company’s total debt is the sum of all current and non-current debts.
ViewRay - Total debt on balance sheet (from 2014 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | €80.55 M | 34.39% |
| 2021-12-31 | €59.93 M | 8.3% |
| 2020-12-31 | €55.34 M | -9.22% |
| 2019-12-31 | €60.96 M | 25.97% |
| 2018-12-31 | €48.39 M | 30.48% |
| 2017-12-31 | €37.09 M | -11.91% |
| 2016-12-31 | €42.1 M | 58.67% |
| 2015-12-31 | €26.53 M | |
| 2014-11-30 | €0 M | 191.23% |
| 2013-11-30 | €0 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 ViewRay VRAY | €72.81 M | 0.00% | 🇺🇸 USA |
 Varex Imaging
VREX | €0.50 B | 593.86% | 🇺🇸 USA |
 Nano-X Imaging NNOX | €6.32 M | -91.31% | 🇮🇱 Israel |